The third annual meeting of the International Society of Pharmacogenomics (ISP) was held on the island of Santorini (Greece) as part of the second Biologie and Prospective Santorini conference. This conference was entitled From Human Genetic Variations to Prediction of Risks and Responses to Drugs and to the Environment. The meeting was organised by Biologie Prospective, headed by Gerard Siest and the staff of the INSERM Unit 525-Nancy group with the collaboration and support of the ISP and participation of the International Union of Nutritional Sciences (IUNS) task force on genetics and nutrition. The conference was also under the auspices of the French and Greek national societies, European federations and international organisations of laboratory medicine, atherosclerosis and pharmacogenomics. There was an international scientific committee and an international organising committee. The aim of the meeting was to bring together clinicians, laboratory medical scientists and scientists from academic and industrial sources to discuss how human genome variation could be used in understanding drug and nutritional effects on the human body.
Inspiring the minds of the attending scientists was the spectacular view from the Nomikos Conference Centre of the deep blue waters of the Aegean Sea, the distant Islands and the rocky Volcanic outcrop in the Caldera. With the heat of summer bouncing off the stunning white cliff-top buildings, knowledge was bounced from one expert to another enhancing the knowledge of all who attended.
This is a preview of subscription content, access via your institution
